Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Monitoring new oral anticoagulants, managing thrombosis, or both?

Ten Cate H.

Thromb Haemost. 2012 May;107(5):803-5. doi: 10.1160/TH12-03-0130. Epub 2012 Mar 22. No abstract available.

PMID:
22437154
[PubMed - indexed for MEDLINE]
2.

Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.

Douxfils J, Mullier F, Robert S, Chatelain C, Chatelain B, Dogné JM.

Thromb Haemost. 2012 May;107(5):985-97. doi: 10.1160/TH11-11-0804. Epub 2012 Mar 22.

PMID:
22438031
[PubMed - indexed for MEDLINE]
3.

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.

Huisman MV, Lip GY, Diener HC, Brueckmann M, van Ryn J, Clemens A.

Thromb Haemost. 2012 May;107(5):838-47. doi: 10.1160/TH11-10-0718. Epub 2012 Feb 8. Review.

PMID:
22318514
[PubMed - indexed for MEDLINE]
4.

[Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].

Nagler M, Wuillemin W.

Ther Umsch. 2012 Nov;69(11):650-6. doi: 10.1024/0040-5930/a000343. Review. German.

PMID:
23117668
[PubMed - indexed for MEDLINE]
5.

Will direct thrombin inhibition change the boundaries of oral anti-coagulation?

Lomas O, Argyle RA, Prendergast BD.

QJM. 2010 Jun;103(6):429-34. doi: 10.1093/qjmed/hcq024. Epub 2010 Mar 15. No abstract available.

PMID:
20231235
[PubMed - indexed for MEDLINE]
Free Article
6.

Laboratory tests and the new oral anticoagulants.

Tripodi A.

Thromb Res. 2012 Oct;130 Suppl 1:S95-7. doi: 10.1016/j.thromres.2012.08.288. Review.

PMID:
23026677
[PubMed - indexed for MEDLINE]
7.

Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants.

Garcia D, Barrett YC, Ramacciotti E, Weitz JI.

J Thromb Haemost. 2013 Feb;11(2):245-52. doi: 10.1111/jth.12096. Review.

PMID:
23216682
[PubMed - indexed for MEDLINE]
8.

Expanded coverage for warfarin patients in the USA monitoring clotting time at home.

[No authors listed]

Cardiovasc J Afr. 2011 Sep-Oct;22(5):280. No abstract available.

PMID:
21983956
[PubMed - indexed for MEDLINE]
Free Article
9.

New oral antithrombotics: a need for laboratory monitoring. For.

Mismetti P, Laporte S.

J Thromb Haemost. 2010 Apr;8(4):621-6. doi: 10.1111/j.1538-7836.2010.03764.x. Epub 2010 Jan 21. No abstract available.

PMID:
20102486
[PubMed - indexed for MEDLINE]
10.

New oral antithrombotics: a need for laboratory monitoring. Against.

Bounameaux H, Reber G.

J Thromb Haemost. 2010 Apr;8(4):627-30. doi: 10.1111/j.1538-7836.2010.03759.x. Epub 2010 Jan 21. No abstract available.

PMID:
20088926
[PubMed - indexed for MEDLINE]
11.

Laboratory tests during direct oral anticoagulant treatment? Yes.

Pengo V.

Intern Emerg Med. 2013 Aug;8(5):371-2. doi: 10.1007/s11739-013-0949-3. Epub 2013 May 21. No abstract available.

PMID:
23686690
[PubMed - indexed for MEDLINE]
12.

Do new oral anticoagulants require laboratory monitoring? The clinician point of view.

Samama MM, Guinet C, Le Flem L.

Thromb Res. 2012 Oct;130 Suppl 1:S88-9. doi: 10.1016/j.thromres.2012.08.286.

PMID:
23026675
[PubMed - indexed for MEDLINE]
13.

Laboratory tests during direct oral anticoagulant treatment? No.

Di Minno G, Ricciardi E, Scalera A.

Intern Emerg Med. 2013 Aug;8(5):367-70. doi: 10.1007/s11739-013-0948-4. Epub 2013 May 21. No abstract available.

PMID:
23686689
[PubMed - indexed for MEDLINE]
14.

Laboratory monitoring of new anticoagulants.

Castellone DD, Van Cott EM.

Am J Hematol. 2010 Mar;85(3):185-7. doi: 10.1002/ajh.21607. Review.

PMID:
20131309
[PubMed - indexed for MEDLINE]
15.

[Pharmacoeconomic analysis of dabigatran etexilate effectiveness in patients with nonvalvular atrial fibrillation].

Belousov IuB, Mareev VIu, Iavelov IS, Belousov DIu, Afanas'eva EV.

Kardiologiia. 2012;52(1):44-51. Russian. No abstract available.

PMID:
22304352
[PubMed - indexed for MEDLINE]
16.

[Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions].

Panchenko EP.

Kardiologiia. 2011;51(11):83-90. Review. Russian. No abstract available.

PMID:
22117775
[PubMed - indexed for MEDLINE]
17.

[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].

Gassanov N, Caglayan E, Erdmann E, Er F.

Dtsch Med Wochenschr. 2010 Feb;135(6):256-9. doi: 10.1055/s-0030-1247864. Epub 2010 Jan 26. Review. German. No abstract available.

PMID:
20104442
[PubMed - indexed for MEDLINE]
18.

Practice guidelines for reversal of new and old anticoagulants.

Hartman SK, Teruya J.

Dis Mon. 2012 Aug;58(8):448-61. doi: 10.1016/j.disamonth.2012.04.003. Review. No abstract available.

PMID:
22818559
[PubMed - indexed for MEDLINE]
19.

New options with dabigatran etexilate in anticoagulant therapy.

Maegdefessel L, Spin JM, Azuma J, Tsao PS.

Vasc Health Risk Manag. 2010 May 25;6:339-49. Review.

PMID:
20531953
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Is patient self-testing a good thing?

Oertel LB, Libby EN.

J Thromb Thrombolysis. 2010 Feb;29(2):214-8. doi: 10.1007/s11239-009-0414-3. No abstract available.

PMID:
19902148
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk